Non-epithelial ovarian cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Colombo, N ^a   Peiretti, M ^a   Castiglione, M ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CHORIONIC GONADOTROPIN; INHIBIN; LACTATE DEHYDROGENASE; PLATINUM COMPLEX;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; DISEASE SEVERITY; EARLY DIAGNOSIS; FOLLOW UP; GERM CELL TUMOR; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX CORD TUMOR; TREATMENT RESPONSE;

EID: 66549084297     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp118     Document Type: Article

References (15)

1. Young RC, Knapp RC et al. Cap 33 cáncer de ovario: Cáncer, principios y práctica de oncología. In Vincent T (ed.), Devita, 2nd edition. Barcelona: Salvat 1988; 1008-1018.
2. Merino MJ, Jaffe G. Age contrast in ovarian pathology. Cancer 1993; 71 (Suppl): 537-544.
3. Horn-Ross PL, Whittemore AS et al. Collaborative Ovarian Cancer Group, 1992 characteristics relating to ovarian cancer risk. Collaborative analysis of 12 US case-control studies. VI. Nonepithelial cancers among adults. Epidemiology 1992; 3: 490-495.
4. Evans AT, Gaffey TA, Malkasian GD et al. Clinicopathologic review of 118 granulosa and 82 theca cells tumors. Obstet Gynecol 1980; 55: 231-238.
5. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981; 11: 261-274.
6. Gershenson DM. Update on malignant ovarian germ cell tumors. Cancer 1993; 71: 1581-1590.
7. Zhang M, Cheung MK, Shin JY et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - an analysis of 376 women. Gynecol Oncol 2007; 104: 396-400.
8. Kurman RJ, Scardino PT, Waldmann TA et al. Malignant germ cell tumors of the ovary and testis: An immunohistologic study of 69 cases. Ann Clin Lab Sci 1979; 9: 462-466.
9. Obata NH, Nakashima N, Kawai M et al. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype. Gynecol Oncol 1995; 58: 124-128.
10. Hildebrandt RH, Rouse RV, Longacre TA. Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol 1997; 28: 1387-1395.
11. Malmstrom H, Hogberg T, Risberg B et al. Granulosa cell tumor of the ovary: Prognostic factors and outcome. Gynecol Oncol 1994; 52: 50-55.
12. Gershenson DM. Management of early ovarian cancer: Germ cell and sex-cord stromal tumors. Gynecol Oncol 1994; 55: S62-S72.
13. Bajorin DF, Sarosdy MF, Pfister GD et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multi-institutional study. J Clin Oncol 1993; 11: 598-606.
14. Homesley HD, Bundy BN, Hurteau JA et al. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol 1999; 72: 131-137.
15. Williams SD, Blessing JA, Hatch KHomesley HD. Chemotherapy of advanced ovarian dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 1991; 9: 1950-1955.